# To Evaluate the Safety of Autologous Tumor-infiltrating Lymphocytes(TILs) for the Treatment of Recurrent Ovarian Cancer

> **NCT07651124** · NA · RECRUITING · sponsor: **Yong Wha Moon** · enrollment: 6 (estimated)

## Conditions studied

- Recurrent Ovarian Cancer

## Interventions

- **OTHER:** autologous tumor-infiltrating lymphocytes

## Key facts

- **NCT ID:** NCT07651124
- **Lead sponsor:** Yong Wha Moon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-06-30
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2026-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07651124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07651124, "To Evaluate the Safety of Autologous Tumor-infiltrating Lymphocytes(TILs) for the Treatment of Recurrent Ovarian Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07651124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*